The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis

International Journal of Pharmaceutics

Volumn 454, Issue 2, 2013, Pages 738-747

  Lépinoux Chambaud, Claire ^a   Eyer, Joël ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Endocytosis; Glioblastoma; Peptide; Tyrosine kinase receptor; Uptake

Indexed keywords

CELL PENETRATING PEPTIDE; GLYCOSAMINOGLYCAN; NFL TBS 40 63 PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG UPTAKE; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; GENE TRANSLOCATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE VESICLE; MICROTUBULE ASSEMBLY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR MODEL;

4′,6′-DIAMIDINO-2-PHENYLINDOLE; 5-(N,N-DIMETHYL) AMILORIDE HYDROCHLORIDE; ADENOSINE TRIPHOSPHATE; ANTENNAPEDIA-HOMEODOMAIN-DERIVED ANTENNAPEDIA; ANTP; ARGININE-GLYCINE-ASPARTIC ACID; ATP; BOVINE SERUM ALBUMIN; BSA; CELL PENETRATING PEPTIDE; CHLORPR.; CHLORPROMAZINE HYDROCHLORIDE; CPP; CYTOCH. D; CYTOCHALASIN D; DAPI; DITHIOTHREITOL; DMA; DMEM; DTT; DUBELCCO'S MODIFIED EAGLES MEDIUM; EGFR; ENDOCYTOSIS; EPIDERMAL GROWTH FACTOR RECEPTOR; FACS; FITC; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENCE ACTIVATED CELL SORTING; GIANT PLASMA MEMBRANE VESICLES; GLIOBLASTOMA; GPMV; HEPARAN SULFATE PROTEOGLYCANS; HSPGS; MAPK; METHYL-Β-CYCLODEXTRIN; MITOGEN-ACTIVATED PROTEIN KINASE; MΒCD; NACLO(3); NEUROFILAMENT LIGHT SUBUNIT; NFL; PARAFORMALDEHYDE; PBS; PDGFR; PEPTIDE; PFA; PHORBOL 12-MYRISTATE 13-ACETATE; PHOSPHATASE AND TENSIN HOMOLOG; PHOSPHATE BUFFERED SALINE; PHOSPHOINOSITIDE 3-KINASE; PI; PI3K; PLATELET-DERIVED GROWTH FACTOR RECEPTOR; PMA; PROPIDIUM IODIDE; PTEN; RGD; RIBONUCLEASE; RNASE; RTK; SODIUM CHLORATE; TAT; TBS; TP10; TRANS-ACTIVATOR OF TRANSCRIPTION; TRANSPORTAN 10; TUBULIN-BINDING SITE; TYROSINE KINASE RECEPTOR; UPTAKE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR;

ANIMALS; ASTROCYTES; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; ENDOCYTOSIS; GLIOMA; HUMANS; NEUROFILAMENT PROTEINS; PEPTIDE FRAGMENTS; RATS;

EID: 84884164384     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.04.004     Document Type: Article

References (52)

1. Alves, I.D., Jiao, C.Y., Aubry, S., Aussedat, B., Burlina, F., Chassaing, G., Sagan, S., 2010. Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. Biochim. Biophys. Acta 1798, 2231-2239.
2. Amand, H.L., Bostrom, C.L., Lincoln, P., Norden, B., Esbjorner, E.K., 2011. Binding of cell-penetrating penetratin peptides to plasma membrane vesicles correlates directly with cellular uptake. Biochim. Biophys. Acta 1808, 1860-1867.
3. Anderson, H.A., Chen, Y., Norkin, L.C., 1996. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7, 1825-1834. (Pubitemid 26386733)
4. Balzeau, J., Peterson, A., Eyer, J., 2012. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells. Int. J. Pharm. 423, 77-83.
5. Balzeau, J., Pinier, M., Berges, R., Saulnier, P., Benoit, J.-P., Eyer, J., 2013. The NFL-TBS. 40-63 peptide improves the in vitro and in vivo targeted uptake of lipid nanocapsules by glioblastoma cells. Biomaterials 34, 3381-3389.
6. Bauer, B., Davidson, M., Orwar, O., 2009. Proteomic analysis of plasma membrane vesicles. Angew. Chem. Int. Ed. Engl. 48, 1656-1659.
7. Berges, R., Balzeau, J., Peterson, A.C., Eyer, J., 2012a. A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis. Mol. Ther. 20, 1367-1377.
8. Berges, R., Balzeau, J., Takahashi, M., Prevost, C., Eyer, J., 2012b. Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit. PLoS ONE 7, e49436.
9. Bocquet, A., Berges, R., Frank, R., Robert, P., Peterson, A.C., Eyer, J., 2009. Neurofilaments bind tubulin and modulate its polymerization. J. Neurosci. 29, 11043-11054.
10. Bonaccorsi, L., Nosi, D., Muratori, M., Formigli, L., Forti, G., Baldi, E., 2007. Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines. J. Mol. Endocrinol. 38, 51-66. (Pubitemid 46351592)
11. Cheng, C.K., Fan, Q.W., Weiss, W.A., 2009. PI3K signalling in glioma - animal models and therapeutic challenges. Brain Pathol. 19, 112-120.
12. Czech, M.P., 2000. PIP2 and PIP3: complex roles at the cell surface. Cell 100, 603-606.
13. Dijkgraaf, I., Yim, C.B., Franssen, G.M., Schuit, R.C., Luurtsema, G., Liu, S., Oyen, W.J., Boerman, O.C., 2011. PET imaging of alphavbeta(3) integrin expression in tumours with (6)(8)Ga-labelled mono-, di- and tetrameric RGD peptides. Eur. J. Nucl. Med. Mol. Imaging 38, 128-137.
14. Dimitropoulos, K., Giannopoulou, E., Argyriou, A.A., Zolota, V., Petsas, T., Tsiata, E., Kalofonos, H.P., 2010. The effects of anti-VEGFR and anti-EGFR agents on glioma cell migration through implication of growth factors with integrins. Anticancer Res. 30, 4987-4992.
15. Doherty, G.J., McMahon, H.T., 2009. Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857-902.
16. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., Brock, R., 2007. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866. (Pubitemid 46971632)
17. Eierhoff, T., Hrincius, E.R., Rescher, U., Ludwig, S., Ehrhardt, C., 2010. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 6, e1001099.
18. Fan, Q.W., Weiss, W.A., 2010. Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance. Curr. Top. Microbiol. Immunol. 347, 279-296.
19. Fawzi, A., Robinet, A., Monboisse, J.C., Ziaie, Z., Kefalides, N.A., Bellon, G., 2000. A peptide of the alpha 3(IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal. 12, 327-335. (Pubitemid 30261548)
20. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., Sugiura, Y., 2001. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840.
21. Gladson, C.L., Cheresh, D.A., 1991. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J. Clin. Invest. 88, 1924-1932.
22. Jiao, C.Y., Delaroche, D., Burlina, F., Alves, I.D., Chassaing, G., Sagan, S., 2009. Translocation and endocytosis for cell-penetrating peptide internalization. J. Biol. Chem. 284, 33957-33965.
23. Gump, J.M., June, R.K., Dowdy, S.F., 2010. Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction. J. Biol. Chem. 285, 1500-1507.
24. Koivusalo, M., Welch, C., Hayashi, H., Scott, C.C., Kim, M., Alexander, T., Touret, N., Hahn, K.M., Grinstein, S., 2010. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signalling. J. Cell Biol. 188, 547-563.
25. Larkin, J.M., Brown, M.S., Goldstein, J.L., Anderson, R.G., 1983. Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts. Cell 33, 273-285. (Pubitemid 13096456)
26. Le Roy, C., Wrana, J.L., 2005. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6, 112-126. (Pubitemid 40215807)
27. Letoha, T., Keller-Pinter, A., Kusz, E., Kolozsi, C., Bozso, Z., Toth, G., Vizler, C., Olah, Z., Szilak, L., 2010. Cell-penetrating peptide exploited syndecans. Biochim. Biophys. Acta 1798, 2258-2265.
28. Lindgren, M., Hallbrink, M., Prochiantz, A., Langel, U., 2000. Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103. (Pubitemid 30114324)
29. Madani, F., Lindberg, S., Langel, U., Futaki, S., Graslund, A., 2011. Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys. 2011, 414729.
30. Mueller, J., Kretzschmar, I., Volkmer, R., Boisguerin, P., 2008. Comparison of cellular uptake using 22 CPPs in 4 different cell lines. Bioconjug. Chem. 19, 2363-2374.
31. Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J.C., Jones, A.T., Sugiura, Y., Futaki, S., 2004. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10, 1011-1022.
32. Nascimento, F.D., Hayashi, M.A., Kerkis, A., Oliveira, V., Oliveira, E.B., Radis-Baptista, G., Nader, H.B., Yamane, T., Tersariol, I.L., Kerkis, I., 2007. Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J. Biol. Chem. 282, 21349-21360. (Pubitemid 47099945)
33. Nikiforova, M.N., Hamilton, R.L., 2011. Molecular diagnostics of gliomas. Arch. Pathol. Lab Med. 135, 558-568.
34. Radis-Baptista, G., de la Torre, B.G., Andreu, D., 2012. Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells. Chem. Biol. Drug Des. 79, 907-915.
35. Raiborg, C., Schink, K.O., Stenmark, H., 2013. Class III phosphatidylinositol 3-kinase and its catalytic product PtdIns3P in regulation of endocytic membrane traffic. FEBS J., http://dx.doi.org/10.1111/febs.12116.
36. Richard, J.P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., Chernomordik, L.V., Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280, 15300-15306.
37. Richard, J.P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M.J., Chernomordik, L.V., Lebleu, B., 2003. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590. (Pubitemid 36043612)
38. Rodal, S.K., Skretting, G., Garred, O., Vilhardt, F., van Deurs, B., Sandvig, K., 1999. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10, 961-974.
39. Saalik, P., Niinep, A., Pae, J., Hansen, M., Lubenets, D., Langel, U., Pooga, M., 2011. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles. J. Control. Release 153, 117-125.
40. Safaiyan, F., Kolset, S.O., Prydz, K., Gottfridsson, E., Lindahl, U., Salmivirta, M., 1999. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J. Biol. Chem. 274, 36267-36273.
41. Sallinen, S.L., Sallinen, P.K., Haapasalo, H.K., Helin, H.J., Helen, P.T., Schraml, P., Kallioniemi, O.P., Kononen, J., 2000. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 60, 6617-6622.
42. Schelhaas, M., Shah, B., Holzer, M., Blattmann, P., Kuhling, L., Day, P.M., Schiller, J.T., Helenius, A., 2012. Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog. 8, e1002657.
43. Seger, R., Krebs, E.G., 1995. The MAPK signalling cascade. FASEB J. 9, 726-735.
44. Shi, J., Zhou, Y., Chakraborty, S., Kim, Y.S., Jia, B., Wang, F., Liu, S., 2011. Evaluation of in-labelled cyclic RGD peptides: effects of peptide and linker multiplicity on their tumour uptake, excretion kinetics and metabolic stability. Theranostics 1, 322-340.
45. Steck, P.A., Moser, R.P., Bruner, J.M., Liang, L., Freidman, A.N., Hwang, T.L., Yung, W.K., Altered expression and distribution of heparan sulfate proteoglycans in human gliomas. Cancer Res. 49, 2096-2103.
46. Stupp, R., Hegi, M.E., Mason, W.P., van den Bent, M.J., Taphoorn, M.J., Janzer, R.C., Ludwin, S.K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A.A., Gijtenbeek, J., Marosi, C., Vecht, C.J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J.G., Mirimanoff, R.O., 2009. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466.
47. Subrizi, A., Tuominen, E., Bunker, A., Rog, T., Antopolsky, M., Urtti, A., 2011. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake. J. Control. Release 158, 277-285.
48. Thevenard, J., Floquet, N., Ramont, L., Prost, E., Nuzillard, J.M., Dauchez, M., Yezid, H., Alix, A.J., Maquart, F.X., Monboisse, J.C., Brassart-Pasco, S., 2006. Structural and antitumour properties of the YSNSG cyclopeptide derived from tumstatin. Chem. Biol. 13, 1307-1315. (Pubitemid 44932235)
49. The Cancer Genome Atlas Research Network, 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
50. Vives, E., Brodin, P., Lebleu, B., 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017. (Pubitemid 27265584)
51. Wadia, J.S., Stan, R.V., Dowdy, S.F., 2004. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315. (Pubitemid 38667624)
52. Yukawa, H., Noguchi, H., Nakase, I., Miyamoto, Y., Oishi, K., Hamajima, N., Futaki, S., Hayashi, S., 2010. Transduction of cell-penetrating peptides into induced pluripotent stem cells. Cell Trans. 19, 901-909.